David Dingli Selected Research

Immunoglobulin Light-chain Amyloidosis

1/2022	Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome.
1/2022	Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis.
12/2021	Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707-715.
3/2021	Characterization and prognostic implication of delayed complete response in AL amyloidosis.
1/2021	Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
1/2021	Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis.
1/2021	Prognostic restaging after treatment initiation in patients with AL amyloidosis.
1/2021	Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) Amyloidosis.
1/2021	Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
1/2021	MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Dingli Research Topics

Disease

100	Multiple Myeloma 10/2022 - 12/2002
64	Immunoglobulin Light-chain Amyloidosis 01/2022 - 10/2009
33	Neoplasms (Cancer) 02/2022 - 12/2002
29	Amyloidosis 11/2022 - 07/2007
7	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 10/2011
7	POEMS Syndrome (Syndrome, POEMS) 01/2022 - 05/2008
7	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021 - 09/2010
6	Anemia 11/2020 - 07/2004
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2016 - 03/2007
5	Disease Progression 04/2022 - 12/2005
5	Proteinuria 01/2022 - 06/2013
4	Thrombocytosis (Thrombocythemia) 01/2022 - 08/2004
4	Infections 11/2021 - 01/2009
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 05/2017
3	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 02/2022 - 11/2008
3	Thrombosis (Thrombus) 01/2022 - 05/2005
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2012
3	Trisomy (Trisomies) 12/2020 - 01/2019
3	Measles 01/2019 - 07/2014
3	Fever (Fevers) 01/2019 - 01/2012
3	Acute Kidney Injury (Acute Renal Failure) 06/2018 - 01/2012
3	Lymphoma (Lymphomas) 01/2018 - 05/2017
3	Leukemia 03/2016 - 06/2006
3	Plasmacytoma 07/2014 - 09/2006
3	Virus Diseases (Viral Diseases) 09/2012 - 01/2009
3	Primary Myelofibrosis (Myelosclerosis) 02/2006 - 07/2004
2	Fatigue 02/2022 - 01/2020
2	Splenomegaly 01/2022 - 07/2004
2	Hypoalbuminemia 01/2022 - 01/2022
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 08/2005
2	Plasma Cell Leukemia 01/2021 - 01/2021
2	Cytokine Release Syndrome 01/2021 - 11/2019
2	Albuminuria 12/2020 - 11/2016
2	Thrombotic Microangiopathies 07/2020 - 01/2016
2	Diarrhea 01/2020 - 07/2007
2	Smoldering Multiple Myeloma 01/2020 - 05/2016
2	Rare Diseases (Rare Disease) 01/2019 - 07/2012
2	Frailty 12/2018 - 11/2016
2	Heart Failure 11/2018 - 06/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2018 - 05/2008
2	Hemolysis 01/2018 - 11/2008
2	Polyradiculoneuropathy (Polyradiculoneuritis) 09/2013 - 07/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2010 - 01/2009

Drug/Important Bio-Agent (IBA)

24	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2005
17	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2008
17	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021 - 06/2012
15	Lenalidomide (CC 5013)FDA Link 01/2021 - 07/2009
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2006
11	Pharmaceutical PreparationsIBA 01/2022 - 12/2002
10	Immunoglobulin M (IgM)IBA 01/2021 - 07/2007
9	sodium-iodide symporter (sodium iodide symporter)IBA 01/2022 - 12/2003
9	Bortezomib (Velcade)FDA Link 01/2022 - 02/2012
8	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 06/2010
7	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 10/2010
7	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2015
6	Immunomodulating AgentsIBA 01/2022 - 10/2009
6	pomalidomideIBA 03/2021 - 10/2009
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2005
5	Proteasome InhibitorsIBA 01/2022 - 11/2015
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 02/2006
5	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 09/2006
5	Imatinib Mesylate (Gleevec)FDA Link 10/2016 - 03/2007
5	Thalidomide (Thalomid)FDA Link 08/2011 - 12/2005
5	IodidesIBA 08/2010 - 07/2003
4	selinexorIBA 09/2021 - 01/2018
4	Troponin T (Troponin T1)IBA 01/2021 - 03/2012
4	daratumumabIBA 01/2021 - 11/2017
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 03/2012
4	VaccinesIBA 01/2019 - 03/2004
4	Rituximab (Mabthera)FDA Link 08/2018 - 09/2010
3	ixazomibIBA 01/2022 - 11/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
3	Immunoglobulin G (IgG)IBA 01/2022 - 05/2015
3	Immunoglobulin A (IgA)IBA 01/2021 - 05/2015
3	CreatinineIBA 12/2020 - 06/2013
3	thiamine triphosphorate (TTP)IBA 06/2015 - 03/2006
2	venetoclaxIBA 01/2021 - 11/2020
2	plerixafor FDA Link 01/2021 - 01/2018
2	AntigensIBA 01/2021 - 01/2017
2	AlbuminsIBA 12/2020 - 01/2016
2	Exportin 1 ProteinIBA 01/2020 - 01/2018
2	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2019 - 01/2019
2	Radioisotopes (Radionuclides)IBA 10/2018 - 12/2004
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 08/2009
2	Congo RedIBA 11/2017 - 10/2016
2	Alkylating AgentsIBA 05/2012 - 03/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011 - 05/2008
2	Diphosphonates (Bisphosphonates)IBA 07/2010 - 08/2006

Therapy/Procedure

108	Therapeutics 11/2022 - 12/2002
60	Stem Cell Transplantation 11/2022 - 12/2002
11	Drug Therapy (Chemotherapy) 01/2021 - 07/2007
7	Hematopoietic Stem Cell Transplantation 03/2021 - 02/2006
6	Transplantation 10/2022 - 04/2006
5	Kidney Transplantation 04/2022 - 06/2011
3	Autologous Transplantation 01/2017 - 12/2009
2	Hematopoietic Stem Cell Mobilization 01/2021 - 01/2018
2	Aftercare (After-Treatment) 01/2021 - 01/2021
2	Oncolytic Virotherapy 10/2018 - 07/2014
2	Renal Dialysis (Hemodialysis) 01/2016 - 01/2014
2	Radiotherapy 08/2010 - 07/2003